My watch list
my.bionity.com  
Login  

S-TARget therapeutics is a biotech start-up company founded in September 2010, that develops novel therapeutic vaccines to cure and prevent allergic diseases. S-TARget‘s vaccines are based on a unique, proprietary technology platform that addresses the cause of the disease not only the symptoms. They are directed against major, widespread allergic diseases that currently cannot be cured – including severe forms of allergy. Lead candidate SG100 targets allergic asthma induced by house dust mite (HDM), the major cause of allergy in the Western world. S-TARget therapeutics was founded by two experienced, senior pharma professionals with top-level research & development and management backgrounds. The privately held company is based in Vienna/Austria

Gründer

Geert Mudde
Founder

More about S-TARget therapeutics
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE